Global Market Study on Autogenous Vaccines: Demand Surging from Livestock Farming Companies and Veterinary Research Institutes

Global Market Study on Autogenous Vaccines: Demand Surging from Livestock Farming Companies and Veterinary Research Institutes

  • Persistence Market Research
  • April 2021
  • Healthcare
  • 214 pages

Report Description

Autogenous Vaccines Market - Scope of Report

A latest publication by Persistence Market Research on the global autogenous vaccine market evaluates the opportunities and current market landscape, and provides detailed analysis and updates about corresponding sections amplifying the viewpoints of the market. The study offers detailed insights on key market dynamics, which include the drivers, restraints, trends, and opportunities in the market. The principal aim of the market study is to present exclusive information about how the market will perform during the forecast period of 2021-2031.

Important indicators for successful growth of the autogenous vaccines market are presented in this comprehensive report, which include Year-on-Year (Y-o-Y) growth analysis of the market, and compounded annual growth rate (CAGR), which are described in an exhaustive way in Persistence Market Research's study. This research study can support readers to know the demand for autogenous vaccines and the quantitative development opportunities during the study period.

The research is beneficial for shareholders in the market, including investors, manufacturers, service providers, distributors, and suppliers, and can help them in developing suitable business strategies to grow in the market. Data insights and assessment presented in this Persistence Market Research study can be leveraged by shareholders in the autogenous vaccines market, industry experts, investors, researchers, reporters, as well as business enthusiasts.

Market statistics as well as information linked to the macro- as well as micro-economic variables affecting the business scenario in the market are also included in the current study. Depending on potential developments in the market, substantive insights are also encountered in this report. Additionally, by virtue of the data submitted in this report, minor companies and new entrants in the autogenous vaccines industry can be aided in making suitable company choices to achieve traction in the market.

Key Market Segments

Persistence Market Research’s study on the autogenous vaccines market offers information divided into three important segments —strain, end user, and region. This report offers comprehensive data and information about the important market dynamics and growth parameters associated with these categories.

By Strain Type

  • Bacterial Strain
  • Viral Strain

End Users

  • Veterinary Research Institutes
  • Livestock Farming Companies
  • Veterinary Clinics and Hospitals

Region

  • North America
  • Latin America
  • Europe
  • Asia Pacific
  • MEA

Key Questions Answered in Report

  • Which geographic regions will continue to remain the most profitable markets for autogenous vaccine manufacturers?
  • Which parameters will bring a change in the demand for autogenous vaccines during the forecast period?
  • How will changing trends impact the market?
  • How will the COVID-19 pandemic impact market growth?
  • How can market players capture the low-hanging opportunities in developed regions?
  • What are the winning strategies of stakeholders in the autogenous vaccines market to upscale their position in this landscape?
  • What are the restraints that investors need to be aware of and might tackle while investing in the market?
  • What are the developmental trends that will impact the market?
  • How can businesses dealing in autogenous vaccines avail the growth opportunities in developed and emerging sectors?

Research Methodology

In Persistence Market Research’s study, a unique research methodology is utilized to conduct extensive research on the growth of autogenous vaccines market, and reach conclusions on the future growth parameters of the market. This research methodology is a combination of primary and secondary research, which helps analysts ensure the accuracy and reliability of the conclusions.

Secondary resources referred to by analysts during the production of the market study include statistics from governmental organizations, trade journals, white papers, and internal and external proprietary databases. Analysts have interviewed senior managers, product portfolio managers, CEOs, VPs, marketing/product managers, and market intelligence managers, who contributed to the development of this report as a primary resource.

Comprehensive information acquired from primary and secondary resources acts as a validation from companies in the market, and makes Persistence Market Research’s projections on the growth prospects of the autogenous vaccines market more accurate and reliable.

Have query on this report?

Make an Enquiry

Table of Content

1. Executaive Summary
1.1. Global Market Outlook
1.2. Demand Side Trends
1.3. Supply Side Trends
1.4. Analysis and Recommendations

2. Market Overview
2.1. Market Coverage / Taxonomy
2.2. Market Definition / Scope / Limitations
2.3. Inclusion and Exclusions

3. Key Market Trends
3.1. Key Trends Impacting the Market
3.2. Mergers & Acquisitions
3.3. Parent Market Analysis 

4. Key Success Factors 
4.1. Regulatory Scenario
4.2. Preventative Measures for Herd Health
4.3. Epidemiology of Various Veterinary Diseases (E.g. Pinkeye)

5. Global Autogenous Vaccine Market Value (US$ Mn) Analysis 2016-2020 and Forecast, 2021-2031
5.1. Historical Market Value (US$ Mn) Analysis, 2016-2020
5.2. Current and Future Market Value (US$ Mn) Projections, 2021-2031
5.2.1. Y-o-Y Growth Trend Analysis
5.2.2. Absolute $ Opportunity Analysis

6. Market Background
6.1. Macro-Economic Factors 
6.1.1. R&D Expenditure
6.1.2. Global Animal Healthcare Expenditure Outlook
6.2. Forecast Factors - Relevance & Impact
6.2.1. Disease Prevalence and Growth
6.2.2. Advancements in Biotechnology and Veterinary Science
6.2.3. Increased Funding and Support for Animal Disease
6.2.4. Adoption Rate
6.3. Market Dynamics
6.3.1. Drivers
6.3.2. Restraints 
6.3.3. Opportunities

7. COVID 19 Crisis Analysis 
7.1. Current COVID19 Statistics and Probable Future Impact
7.2. Current GDP Projection and Probable Impact
7.3. Current Economic Projection as compared to 2008 financial analysis
7.4. COVID19 and Impact Analysis
7.4.1. Revenue By Strain
7.4.2. Revenue By Country
7.5. 2020 Market Scenario
7.6. Recovery Scenario – Short term, Midterm and Long Term Impact

8. Global Autogenous Vaccines Market Analysis 2016-2020 and Forecast 2021-2031, By Strain
8.1. Introduction / Key Findings
8.2. Historical Market Size (US$ Mn) By Strain, 2016-2020
8.3. Current and Future Market Size (US$ Mn) Analysis and Forecast By Strain, 2021-2031
8.3.1. Bacterial Strain
8.3.2. Virus Strain
8.4. Market Attractiveness Analysis By Strain

9. Global Autogenous Vaccines Market Analysis 2016-2020 and Forecast 2021-2031, by End User 
9.1. Introduction / Key Findings
9.2. Historical Market Size (US$ Mn) By Application, 2016-2020
9.3. Current and Future Market Size (US$ Mn) Analysis and Forecast By End User, 2021-2031
9.3.1. Veterinary Research Institute
9.3.2. Livestock Farming Companies
9.3.3. Veterinary Clinics and Hospitals
9.4. Market Attractiveness Analysis By End User 

10. Global Autogenous Vaccines Market Analysis 2016-2020 and Forecast 2021-2031, by Region
10.1. Introduction
10.2. Historical Market Size (US$ Mn) Analysis By Region, 2014 - 2018
10.3. Current Market Size (US$ Mn) Analysis and Forecast By Region, 2021 - 2031
10.3.1. North America
10.3.2. Latin America
10.3.3. Europe
10.3.4. Asia Pacific
10.3.5. Middle East and Africa (MEA)
10.4. Market Attractiveness Analysis By Region

11. North America Autogenous Vaccines Market Analysis 2016-2020 and Forecast 2021-2031
11.1. Introduction
11.2. Historical Market Size (US$ Mn) Trend Analysis By Market Taxonomy, 2016-2020
11.3. Market Size (US$ Mn) Forecast By Market Taxonomy, 2021-2031
11.3.1. By Country
11.3.1.1. U.S.
11.3.1.2. Canada
11.3.2. By Strain
11.3.3. By End User
11.4. Market Attractiveness Analysis

12. Latin America Autogenous Vaccines Market Analysis 2016-2020 and Forecast 2021-2031
12.1. Introduction
12.2. Historical Market Size (US$ Mn) Trend Analysis By Market Taxonomy, 2016 - 2020
12.3. Market Size (US$ Mn) Forecast By Market Taxonomy, 2021-2031
12.3.1. By Country
12.3.1.1. Brazil
12.3.1.2. Mexico
12.3.1.3. Argentina
12.3.1.4. Rest of Latin America
12.3.2. By Strain
12.3.3. By End User
12.4. Market Attractiveness Analysis

13. Europe Autogenous Vaccines Market Analysis 2016-2020 and Forecast 2021-2031
13.1. Introduction
13.2. Historical Market Size (US$ Mn) Trend Analysis By Market Taxonomy, 2016-2020
13.3. Market Size (US$ Mn) Forecast By Market Taxonomy2021-2031
13.3.1. By Country
13.3.1.1. Germany
13.3.1.2. Italy
13.3.1.3. France
13.3.1.4. U.K.
13.3.1.5. Spain
13.3.1.6. Russia
13.3.1.7. Rest of Europe
13.3.2. By Strain
13.3.3. By End User
13.4. Market Attractiveness Analysis

14. Asia Pacific Autogenous Vaccines Market Analysis 2016-2020 and Forecast 2021-2031
14.1. Introduction
14.2. Historical Market Size (US$ Mn) Trend Analysis By Market Taxonomy, 2016-2020
14.3. Market Size (US$ Mn) Forecast By Market Taxonomy2021-2031
14.3.1. By Country
14.3.1.1. Thailand
14.3.1.2. Singapore
14.3.1.3. Japan
14.3.1.4. Australia
14.3.1.5. New Zealand
14.3.2. By Strain
14.3.3. By End User
14.4. Market Attractiveness Analysis
14.5. Key Market Participants - Intensity Mapping
14.6. Drivers and Restraints - Impact Analysis

15. Middle East and Africa Autogenous Vaccines Market Analysis 2016-2020 and Forecast 2021-2031
15.1. Introduction
15.2. Historical Market Size (US$ Mn) Trend Analysis By Market Taxonomy, 2016-2020
15.3. Market Size (US$ Mn) Forecast By Market Taxonomy, 2021-2031
15.3.1. By Country
15.3.1.1. Israel
15.3.1.2. Turkey
15.3.1.3. South Africa 
15.3.1.4. Rest of Middle East and Africa
15.3.2. By Strain
15.3.3. By End User
15.4. Market Attractiveness Analysis

16. Key and Emerging Countries Autogenous Vaccines Market Analysis 2016-2020 and Forecast 2021-2031
16.1. Introduction
16.1.1. Market Value (US$ Mn) Proportion Analysis, By Key Countries
16.1.2. Global Vs. Country Growth Comparison
16.2. U.S. Autogenous Vaccines Market Analysis
16.2.1. By Strain
16.2.2. By End User 
16.3. Canada Autogenous Vaccines Market Analysis
16.3.1. By Strain
16.3.2. By End User 
16.4. Mexico Autogenous Vaccines Market Analysis
16.4.1. By Strain
16.4.2. By End User 
16.5. Brazil Autogenous Vaccines Market Analysis
16.5.1. By Strain
16.5.2. By End User 
16.6. Argentina Autogenous Vaccines Market Analysis
16.6.1. By Strain
16.6.2. By End User 
16.7. U.K. Autogenous Vaccines Market Analysis
16.7.1. By Strain
16.7.2. By End User 
16.8. Germany Autogenous Vaccines Market Analysis
16.8.1. By Strain
16.8.2. By End User 
16.9. France Autogenous Vaccines Market Analysis
16.9.1. By Strain
16.9.2. By End User 
16.10. Italy Autogenous Vaccines Market Analysis
16.10.1. By Strain
16.10.2. By End User 
16.11. Spain Autogenous Vaccines Market Analysis
16.11.1. By Strain
16.11.2. By End User 
16.12. Russia Autogenous Vaccines Market Analysis
16.12.1. By Strain
16.12.2. By End User 
16.13. Thailand Autogenous Vaccines Market Analysis
16.13.1. By Strain
16.13.2. By End User
16.14. Japan Autogenous Vaccines Market Analysis
16.14.1. By Strain
16.14.2. By End User
16.15. Singapore Autogenous Vaccines Market Analysis
16.15.1. By Strain
16.15.2. By End User 
16.16. Australia Autogenous Vaccines Market Analysis
16.16.1. By Strain
16.16.2. By End User 
16.17. New Zealand Autogenous Vaccines Market Analysis
16.17.1. By Strain
16.17.2. By End User 
16.18. Israel Autogenous Vaccines Market Analysis
16.18.1. By Strain
16.18.2. By End User 
16.19. Turkey Autogenous Vaccines Market Analysis
16.19.1. By Strain
16.19.2. By End User 
16.20. South Africa Autogenous Vaccines Market Analysis
16.20.1. By Strain
16.20.2. By End Users

17. Market Structure Analysis
17.1. Market Analysis by Tier of Companies 
17.2. Market Share Analysis of Top Players

18. Competition Analysis
18.1. Competition Dashboard
18.2. Competition Benchmarking
18.3. Competition Deep Dive 
18.3.1. Newport Laboratories, Inc. (Boehringer Ingelheim International GmbH)
18.3.1.1. Overview
18.3.1.2. Strain Portfolio
18.3.1.3. Sales Footprint
18.3.1.4. Analyst Commentary
18.3.1.5. Strategy Overview
18.3.2. Phibro Animal Health 
18.3.2.1. Overview
18.3.2.2. Strain Portfolio
18.3.2.3. Sales Footprint
18.3.2.4. Analyst Commentary
18.3.2.5. Strategy Overview
18.3.3. Elanco Animal Health
18.3.3.1. Overview
18.3.3.2. Strain Portfolio
18.3.3.3. Sales Footprint
18.3.3.4. Analyst Commentary
18.3.3.5. Strategy Overview
18.3.4. Ceva Santé Animale
18.3.4.1. Overview
18.3.4.2. Strain Portfolio
18.3.4.3. Sales Footprint
18.3.4.4. Analyst Commentary
18.3.4.5. Strategy Overview
18.3.5. ACE Laboratory Services (Apiam Animal Health)
18.3.5.1. Overview
18.3.5.2. Strain Portfolio
18.3.5.3. Sales Footprint
18.3.5.4. Analyst Commentary
18.3.5.5. Strategy Overview
18.3.6. Huvepharma, Inc.
18.3.6.1. Overview
18.3.6.2. Strain Portfolio
18.3.6.3. Sales Footprint
18.3.6.4. Analyst Commentary
18.3.6.5. Strategy Overview
18.3.7. AniCon Labor GmbH
18.3.7.1. Overview
18.3.7.2. Strain Portfolio
18.3.7.3. Sales Footprint
18.3.7.4. Analyst Commentary
18.3.7.5. Strategy Overview
18.3.8. Cambridge Technologies
18.3.8.1. Overview
18.3.8.2. Strain Portfolio
18.3.8.3. Sales Footprint
18.3.8.4. Analyst Commentary
18.3.8.5. Strategy Overview
18.3.9. Dyntec s. r. o
18.3.9.1. Overview
18.3.9.2. Strain Portfolio
18.3.9.3. Sales Footprint
18.3.9.4. Analyst Commentary
18.3.9.5. Strategy Overview
18.3.10. Hygieia Biological Laboratories
18.3.10.1. Overview
18.3.10.2. Strain Portfolio
18.3.10.3. Sales Footprint
18.3.10.4. Analyst Commentary
18.3.10.5. Strategy Overview
18.3.11. HIPRA
18.3.11.1. Overview
18.3.11.2. Strain Portfolio
18.3.11.3. Sales Footprint
18.3.11.4. Analyst Commentary
18.3.11.5. Strategy Overview
18.3.12. Vaxxinova
18.3.12.1. Overview
18.3.12.2. Strain Portfolio
18.3.12.3. Sales Footprint
18.3.12.4. Analyst Commentary
18.3.12.5. Strategy Overview
18.3.13. sanphar (ipeve)
18.3.13.1. Overview
18.3.13.2. Strain Portfolio
18.3.13.3. Sales Footprint
18.3.13.4. Analyst Commentary
18.3.13.5. Strategy Overview
18.3.14. Addison Biological Laboratory
18.3.14.1. Overview
18.3.14.2. Strain Portfolio
18.3.14.3. Sales Footprint
18.3.14.4. Analyst Commentary
18.3.14.5. Strategy Overview
18.3.15. Zoetis (PHARMAQ AS)
18.3.15.1. Overview
18.3.15.2. Strain Portfolio
18.3.15.3. Sales Footprint
18.3.15.4. Analyst Commentary
18.3.15.5. Strategy Overview
18.3.16. Barramundi Asia Pte Ltd.(UVAXX Asia)
18.3.16.1. Overview
18.3.16.2. Strain Portfolio
18.3.16.3. Sales Footprint
18.3.16.4. Analyst Commentary
18.3.16.5. Strategy Overview
18.3.17. Kennebec River Biosciences
18.3.17.1. Overview
18.3.17.2. Strain Portfolio
18.3.17.3. Sales Footprint
18.3.17.4. Analyst Commentary
18.3.17.5. Strategy Overview

19. Assumptions and Acronyms Used

20. Research Methodology

List of Table

Table 01: Global Autogenous Vaccines Market Size (US$ Mn) Analysis 2016-2020 and Forecast 2021-2031, By Strain
Table 02: Global Autogenous Vaccines Market Size (US$ Mn) Analysis 2016-2020 and Forecast 2021-2031, By End User
Table 03: Global Autogenous Vaccines Market Size (US$ Mn) Analysis 2016-2020 and Forecast 2021-2031, By Region
Table 04: North America Autogenous Vaccines Market Size (US$ Mn) Analysis 2016-2020 and Forecast 2021-2031, By Country
Table 05: North America Autogenous Vaccines Market Size (US$ Mn) Analysis 2016-2020 and Forecast 2021-2031, By Strain
Table 06: North America Autogenous Vaccines Market Size (US$ Mn) Analysis 2016-2020 and Forecast 2021-2031, By End User
Table 07: Latin America Autogenous Vaccines Market Size (US$ Mn) Analysis 2016-2020 and Forecast 2021-2031, By Country
Table 08: Latin America Autogenous Vaccines Market Size (US$ Mn) Analysis 2016-2020 and Forecast 2021-2031, By Strain
Table 09: Latin America Autogenous Vaccines Market Size (US$ Mn) Analysis 2016-2020 and Forecast 2021-2031, By End User
Table 10: Europe Autogenous Vaccines Market Size (US$ Mn) Analysis 2016-2020 and Forecast 2021-2031, By Country
Table 11: Europe Autogenous Vaccines Market Size (US$ Mn) Analysis 2016-2020 and Forecast 2021-2031, By Strain
Table 12: Europe Autogenous Vaccines Market Size (US$ Mn) Analysis 2016-2020 and Forecast 2021-2031, By End User
Table 13: Asia Pacific Autogenous Vaccines Market Size (US$ Mn) Analysis 2016-2020 and Forecast 2021-2031, By Country
Table 14: Asia Pacific Autogenous Vaccines Market Size (US$ Mn) Analysis 2016-2020 and Forecast 2021-2031, By Strain
Table 15: Asia Pacific Autogenous Vaccines Market Size (US$ Mn) Analysis 2016-2020 and Forecast 2021-2031, By End User
Table 16: MEA Autogenous Vaccines Market Size (US$ Mn) Analysis 2016-2020 and Forecast 2021-2031, By Country
Table 17: MEA Autogenous Vaccines Market Size (US$ Mn) Analysis 2016-2020 and Forecast 2021-2031, By Strain
Table 18: MEA Autogenous Vaccines Market Size (US$ Mn) Analysis 2016-2020 and Forecast 2021-2031, By End User

Success Stories

Our Clients